Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has plans to consult on the use of powers to improve the regulatory environment for clinical trials granted by the Medicines and Medical Devices Act 2021.

The Medicines and Medical Devices Act 2021 provides targeted delegated powers which enable us to update the regulatory regime for clinical trials. Work is ongoing to develop legislative proposals to design a regulatory environment for clinical trials which will support the development of innovative medicines. The Medicines and Healthcare products Regulatory Agency intend to consult on proposals later this year.